TRV GP VI, LLC
- SEC CIK
- 0001990716
Holdings, Q2 2026
Positions as of Jun 30, 2026, filed Aug 7, 2026.SEC
- Positions
- 4
- +1 vs. Q1 2026
- Total value
- $232.28M
- +$96.68M (+71.3%) vs. Q1 2026
Compare with Q1 2026: new, added, reduced and sold out
Positions
Long positions only. Changes compare share counts with Q1 2026.
| Security | Class | Shares | Value | % of portfolio | Change in shares | Action | History |
|---|---|---|---|---|---|---|---|
| SEPNSEPTERNA INC | COM | 4,211,659 | $141.05M | 60.72% | 00.0% | Unchanged | View |
| SPTXSEAPORT THERAPEUTICS INC | COMMON STOCK | 2,061,222 | $44.77M | 19.27% | +2,061,222 | New | View |
| RAPPRAPPORT THERAPEUTICS INC | COM | 969,218 | $40.39M | 17.39% | 00.0% | Unchanged | View |
| TNGXTANGO THERAPEUTICS INC | COM | 194,174 | $6.07M | 2.61% | 00.0% | Unchanged | View |
13F filings by quarter
| Quarter | Filed | Positions | Total value | Changes | Filing |
|---|---|---|---|---|---|
| Q2 2026 | Aug 7, 2026 | 4 | $232.28M | vs. Q1 2026 | SEC |
| Q1 2026 | May 7, 2026 | 3 | $135.6M | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 13, 2026 | 3 | $148.55M | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 13, 2025 | 3 | $109.64M | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 8, 2025 | 4 | $64.22M | vs. Q1 2025 | SEC |
| Q1 2025 | May 9, 2025 | 4 | $41.97M | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 13, 2025 | 4 | $116.91M | – | SEC |